In order to address these shortfalls, in August 2015 the Medical Research Council (MRC) and Engineering and Physical Sciences Research Council (EPSRC) invited proposals to establish a network of high-quality molecular pathology nodes to work collaboratively to:
- Act as multidisciplinary centres of innovative molecular diagnostic test discovery and development bringing together the research base, pathology/genetic services and industry
- Develop novel molecular pathology diagnostic tools targeting identified clinical needs with the input of biomedical, clinical, engineering and physical sciences researchers.
- Cooperate as a network, for the benefit of the UK by, for example, sharing best practice and assisting in the evaluation and diffusion of next generation tests
- Complement partner investments including the National Institute for Health Research Diagnostic Evidence Centres (DEC) and the Technology Strategy Board Precision Medicine Catapult
Six nodes have now been established at the following institutions to achieve this vision: